Cart
sales@molnova.com
SU 5205
CAS No. 3476-86-6
SU 5205( SU 5205 | SU-5205 | SU5205 )
Catalog No. M17490 CAS No. 3476-86-6
SU 5205 is a VEGFR2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU 5205
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU 5205 is a VEGFR2 inhibitor.
-
DescriptionSU 5205 is a VEGFR2 inhibitor.
-
In VitroSU5205 inhibits ligand-induced endothelial mitogenesis for VEGF with an IC50 of 5.1 μM.
-
In Vivo——
-
SynonymsSU 5205 | SU-5205 | SU5205
-
PathwayOthers
-
TargetOther Targets
-
RecptorVEGFR2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number3476-86-6
-
Formula Weight239.25
-
Molecular FormulaC15H10FNO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1044.98 mM)
-
SMILESc1ccc2c(c1)/C(=C\c1ccc(cc1)F)/C(=O)N2
-
Chemical Name2-Indolinone, 3-(p-fluorobenzylidene)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tian XF, et al. PACE4 regulates apoptosis in human pancreatic cancer Panc 1 cells via the mitochondrial signaling pathway. Mol Med Rep. 2016 Dec;14(6):5205-5210.
molnova catalog
related products
-
Zilovertamab
Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.
-
(±)-Equol
Equol is a non-steroidal estrogen produced from the metabolism of the isoflavonoid phytoestrogen daidzen by human intestinal microflora.?
-
5-TAMRA chloride(918...
5-TAMRA can produce bright, pH insensitive orange fluorescence (Ex/ Em= 546 / 579nm), and has good photostability
